RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Quest Diagnostics Stock

Quest Diagnostics Equity 2025

Quest Diagnostics Equity

6.78 B USD

Ticker

DGX

ISIN

US74834L1008

WKN

904533

In 2025, Quest Diagnostics's equity was 6.78 B USD, a 7.47% increase from the 6.31 B USD equity in the previous year.

Quest Diagnostics Aktienanalyse

What does Quest Diagnostics do?

Quest Diagnostics Inc is a leading company in the field of diagnostic information and services, headquartered in New Jersey, USA. The company is dedicated to providing medical professionals and patients worldwide with fast, accurate, and preventive diagnostic tests. The history of Quest Diagnostics dates back to 1967 when the company MetPath was founded by Dr. Paul A. Brown. In the following years, several acquisitions and mergers took place, eventually leading to the establishment of Quest Diagnostics in 1996. Since then, the company has continuously evolved and now offers a wide range of diagnostic tests and services, ranging from the analysis of blood samples to genetic testing procedures. The business model of Quest Diagnostics is based on providing high-quality and individualized information to medical professionals and patients to assist in the diagnosis, treatment, and cure of their health problems. The company works closely with doctors, hospitals, and other medical institutions worldwide to offer a comprehensive range of innovative diagnostic products, procedures, and technologies tailored to meet specific needs. Quest Diagnostics offers a wide range of services, ranging from laboratory testing to data management and clinical trials. The company has various business segments, including the Diagnostic Services business, the Medical Research Services business, and the Information Services business. In the field of Diagnostic Services, Quest Diagnostics offers a broad spectrum of laboratory tests divided into different categories such as cancer diagnostics, cardiology, endocrinology, immunology, and infectious diseases. The company also provides a variety of genetic tests that enable precise analysis of individual genomes, supporting the diagnosis and treatment of various genetic disorders. In the medical research field, Quest Diagnostics provides a range of services to support clinical trials and drug development. The company also offers a wide range of laboratory tests used in biomedical research to improve people's health and well-being. The Information Services business segment of Quest Diagnostics mainly focuses on providing innovative solutions in the field of data management and information technology. This includes the development of software tools that can be used for the analysis and management of health data. Additionally, the company offers consulting services to help medical professionals address challenges related to information processing and data integration. Quest Diagnostics is a company based on innovation and knowledge that collaborates closely with doctors, clinics, and other medical facilities worldwide to offer a relatively comprehensive range of need-specific diagnostic products, procedures, and solutions. From cancer diagnostics to genomic diagnostics, from clinical trials to information and data services, and a wide range of molecular diagnostic tests and laboratory analyses, Quest Diagnostics provides top-notch solutions for optimal patient care, contributing to the goal of improving global healthcare for people worldwide. Quest Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Quest Diagnostics's Equity

Quest Diagnostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Quest Diagnostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Quest Diagnostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Quest Diagnostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Quest Diagnostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Quest Diagnostics stock

What is the equity of Quest Diagnostics this year?

Quest Diagnostics has equity of 6.78 B USD this year.

What was the equity of Quest Diagnostics compared to the previous year?

The equity of Quest Diagnostics has increased/decreased by 7.47% increased compared to the previous year.

What impact does a high equity have on investors of Quest Diagnostics?

A high equity is advantageous for investors of Quest Diagnostics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Quest Diagnostics?

A low equity can be a risk for investors of Quest Diagnostics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Quest Diagnostics affect the company?

An increase in equity of Quest Diagnostics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Quest Diagnostics affect the company?

A reduction in equity of Quest Diagnostics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Quest Diagnostics?

Some factors that can affect the equity of Quest Diagnostics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Quest Diagnostics so important for investors?

The equity of Quest Diagnostics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Quest Diagnostics take to change the equity?

To change equity, Quest Diagnostics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Quest Diagnostics pay?

Over the past 12 months, Quest Diagnostics paid a dividend of 3 USD . This corresponds to a dividend yield of about 1.61 %. For the coming 12 months, Quest Diagnostics is expected to pay a dividend of 2.56 USD.

What is the dividend yield of Quest Diagnostics?

The current dividend yield of Quest Diagnostics is 1.61 %.

When does Quest Diagnostics pay dividends?

Quest Diagnostics pays a quarterly dividend. This is distributed in the months of February, May, August, November.

How secure is the dividend of Quest Diagnostics?

Quest Diagnostics paid dividends every year for the past 25 years.

What is the dividend of Quest Diagnostics?

For the upcoming 12 months, dividends amounting to 2.56 USD are expected. This corresponds to a dividend yield of 1.37 %.

In which sector is Quest Diagnostics located?

Quest Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Quest Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Quest Diagnostics from 10/20/2025 amounting to 0.8 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2025.

When did Quest Diagnostics pay the last dividend?

The last dividend was paid out on 10/20/2025.

What was the dividend of Quest Diagnostics in the year 2024?

In the year 2024, Quest Diagnostics distributed 2.84 USD as dividends.

In which currency does Quest Diagnostics pay out the dividend?

The dividends of Quest Diagnostics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Quest Diagnostics

Our stock analysis for Quest Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quest Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.